Tech Center 1600 • Art Units: 1641 1645
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17672748 | PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18693477 | BACTERIOLYSIS METHOD, BACTERIOLYSIS AID, AND METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF BACTERIA | Non-Final OA | ASAHI KASEI KABUSHIKI KAISHA |
| 18293016 | MICROORGANISMS DISPLAYING VIRAL DECOY RECEPTORS | Non-Final OA | EVONIK OPERATIONS GMBH |
| 18344790 | SURFACE DISPLAYED FUSION PROTEINS | Non-Final OA | Clara Foods Co. |
| 18696177 | ESCHERICHIA COLI HAVING 3-HYDROXYPROPIONATE PRODUCTION ABILITY, WITH 3-HYDROXYPROPIONATE PRODUCTION GENE INSERTED INTO SAME, AND USE THEREOF | Non-Final OA | LG CHEM, LTD. |
| 18701173 | COMPOSITION FOR PREVENTING, TREATING OR ALLEVIATING RHEUMATOID ARTHRITIS COMPRISING PROPIONIBACTERIUM FREUDENREICHII MJ2 STRAIN AS AN ACTIVE INGREDIENT | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18472445 | TARGETING THE IMMUNE SUPPRESSIVE TUMOR MICROENVIRONMENT | Non-Final OA | BROWN UNIVERSITY |
| 18697325 | ENGINEERED VECTORS AND ORGANISMS CONTAINING THE SAME FOR ISOFLAVONE CONVERSION IN THE GUT | Non-Final OA | Board of Regents, The University of Texas System |
| 18028477 | VARIANT STAPHYLOCOCCUS AUREUS LUKA AND LUKB POLYPEPTIDES AND VACCINE COMPOSITIONS | Final Rejection | NEW YORK UNIVERSITY |
| 17787091 | COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST STAPHYLOCOCCUS AUREUS | Final Rejection | Washington University |
| 17434349 | TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM | Non-Final OA | The General Hospital Corporation |
| 18695708 | FISH REARING COMPOSITION, AND COMPOSITION FOR PREVENTING OR TREATING FISH DISEASES | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18935074 | METHODS AND USES OF MICROBIOME COMPOSITIONS | Non-Final OA | MarvelBiome, Inc. |
| 18273779 | COMPOSITION FOR INCREASING MUSCLE MASS AND SUPPRESSING A DECREASE IN MUSCLE MASS, AND COMPOSITION FOR INCREASING MUSCLE MASS AND SUPPRESSING MUSCLE ATROPHY | Non-Final OA | DIC Corporation |
| 18252124 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Non-Final OA | Pfizer Inc. |
| 18255275 | COMPOSITION FOR PREVENTING OR TREATING DETERIORATION IN BRAIN FUNCTION OR MAINTAINING OR IMPROVING BRAIN FUNCTION | Non-Final OA | TOKYO INSTITUTE OF TECHNOLOGY |
| 18698993 | ASSOCIATION OF A FAECALIBACTERIUM PRAUSNITZII STRAIN AND ANTI-PD-1, ANTI-PD-L1 OR ANTI-CTLA-4 ANTIBODIES FOR THE TREATMENT OF CANCER | Non-Final OA | EXELIOM BIOSCIENCES |
| 18695879 | BIO-FUNGICIDES FORMULATIONS FOR INHIBITING PHYTOPHTHORA INFESTANS AND METHOD THEREOF | Non-Final OA | TAMIL NADU AGRICULTURAL UNIVERSITY |
| 18267687 | COMPOSITION FOR IMPROVING INFLAMMATION OF BRAIN TISSUE | Final Rejection | MEIJI CO., LTD. |
| 17906471 | T-CELL BISPECIFIC BINDING PROTEINS | Non-Final OA | CRISPR THERAPEUTICS AG |
| 18001498 | MODIFIED EXOTOXIN A PROTEINS | Non-Final OA | GlaxoSmithKline Biologicals SA |
| 17998194 | PROTEINS AND NUCLEIC ACIDS FOR EHRLICHIA DIAGNOSIS AND VACCINATION | Non-Final OA | Research Development Foundation |
| 18291147 | Recombinant Mycobacterium as an Immunotherapeutic Agent for the Second-Line Therapy of Bladder Carcinoma | Non-Final OA | Serum Institute of India Pvt. Ltd. |
| 18414311 | Albumin-Free Botulinum Toxin Formulations | Non-Final OA | REVANCE THERAPEUTICS, INC. |
| 18264703 | PROBIOTIC COMPOSITION FOR THE TREATMENT OF COVID-19 | Final Rejection | AB-BIOTICS, S.A. |
| 18258950 | USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS | Final Rejection | Fonterra Co-Operative Group Limited |
| 18368505 | VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | Non-Final OA | The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College |
| 18550036 | NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF | Non-Final OA | HOUSTON METHODIST RESEARCH INSTITUTE |
| 18549804 | COMPOSITION AND AMELIORATING AGENT HAVING INFLAMMATION REDUCING EFFECT | Non-Final OA | KYOWA HAKKO BIO CO., LTD. |
| 18281265 | ANTIBACTERIAL METHODS & CELLS | Non-Final OA | Folium Food Science Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy